Blocking a human branched DNA enzyme offers new ways of targeting a crucial enzyme family for cancer
An international team of scientists has discovered how compounds block flap endonuclease 1 (FEN1) - a crucial enzyme class in the DNA damage response and potential target for cancer treatment.